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Human T-cell Leukemia Virus type-1 (HTLV-1) is
highly immunogenic and has low variability so tight reg-
ulation of its expression is essential for virus mainte-
nance in vivo. HTLV-1 replication is positively regulated
by Tax and Rex, and negatively by the p30 and HBZ
proteins. Here, we demonstrate that HTLV-1 encodes
another negative regulator of virus expression, the p13
protein. Expressed separately, p13 localizes to the mito-
chondria, but in the presence of Tax, p13 is stabilized,
and re-routed to the nuclear speckles. The p13 protein
directly binds Tax, decreases Tax binding to the CBP/
p300 transcriptional co-activator and, by reducing Tax
transcriptional activity, suppresses viral expression.
These findings suggest that HTLV-1 has evolved a com-
plex mechanism to control its own replication through
regulation of positive and negative viral proteins.
Further, these results emphasize the importance of
studying the function of the HTLV-1 viral proteins, not
only in isolation, but also in the context of full viral
replication.
Author details
1Animal Models and Retroviral Vaccines Section, National Cancer Institute,
Bethesda, Maryland, 20892, USA.
2Department of Pathology and Laboratory
Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66160,
USA.
Published: 6 June 2011
doi:10.1186/1742-4690-8-S1-A125
Cite this article as: Andresen et al.: Tax-mediated re-routing of the
HTLV-1 p13 protein to nuclear speckles. Retrovirology 2011 8(Suppl 1):
A125.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: franching@mail.nih.gov
1Animal Models and Retroviral Vaccines Section, National Cancer Institute,
Bethesda, Maryland, 20892, USA
Full list of author information is available at the end of the article
Andresen et al. Retrovirology 2011, 8(Suppl 1):A125
http://www.retrovirology.com/content/8/S1/A125
© 2011 Andresen et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.